Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > May 9, 2023
Daily News
May 9, 2023
- PeptiDream Unit Seeks Label Expansion for PET Diagnostic Amyvid
May 9, 2023
- Over 40% of Japan Drug Makers Allow Side Jobs, MSD Has Largest 188 Staffers Tapping Option: Poll
May 9, 2023
- JPMA Nudges Govt to Take Special Measures for Infectious Disease Biz
May 9, 2023
- Chuikyo to Go Back Offline from May, but Online Viewing Still Available
May 9, 2023
- Eisai, BlissBio to Codevelop ADC Using Eribulin
May 9, 2023
- FY2023 COVID Booster Program Begins for Elderly, Health Workers
May 9, 2023
- JPWA Urges Govt to Take Steps against Drug Shortages Based on Overseas Examples
May 9, 2023
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…